Ph. Gabriel Steg

Affiliation: Université de ParisAP‐HP (Assistance Publique‐Hôpitaux de Paris)Hôpital BichatFACT (French Alliance for Cardiovascular Trials)INSERM U‐1148 Paris France

Institution: Université de Paris

ORCID: 0000-0001-6896-2941

External IDs: Scopus Author ID: 56212505300

Works: 0, Cited by: 0, H-index: 0

Affiliations - Chief, Department of Cardiology, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, in Paris, France. - Vice President (in charge of research) of the board of the Assistance Publique-Hôpitaux de Paris network since 2018. - Professor of Cardiology at Université Paris – Diderot (now Université Paris-Cité), since 1994. - Professor of Cardiology, at the National Heart and Lung Institute, Imperial College, London, UK, 2013-2018. - Innovation Chair, Institut Universitaire de France, since 2022. - Director of the “Clinical Research in Atherothrombosis” Research Team 5, INSERM/Université Paris Cité UMR 1148/LVTS, Paris - Coordinator of the iVASC (InnoVations in Atherothrombosis SCience) RHU research consortium 2017-2023. - Chairman of the French National University Council (Conseil National des Universités) for Cardiology since 2016. Honors Dr Steg received the silver medal of the European Society of Cardiology in 2011, the Joseph A Vita Award from the American Heart Association in 2019, the Grand Prix Claude Bernard de la Ville de Paris in 2019 and the Prix Suzanne Clément of the Foundation Simone and Cino Del Duca in 2022. Research Dr Steg has accumulated experience as a clinical trialist in the field of coronary artery disease, diabetes and antithrombotics. He is currently leading several large phase III clinical trials or international registries. He chairs the FACT (French Alliance for Cardiovascular clinical Trials) academic research network since 2013, is Faculty at the Baim Institute for Clinical Research (Boston, MA, USA), and member of the ATLAS Group (Antithrombotic Trials Leadership and Steering Group) academic leaders, affiliated with University of Colorado (CO, USA). Publications Dr Steg has authored > 1200 articles in peer-reviewed international journals. His H-Index is 149 (Web of Science) and he has > 130 000 citations. He has been a Thomson Reuters/Clarivate Analytics “highly cited researcher” in Clinical Medicine every year since 2014. He is Senior Associate Editor for Circulation.

Education

Professor of Cardiology, Université Paris – Diderot (1994-)
Professor of Cardiology, National Heart and Lung Institute, Imperial College, London, UK (2013-2018)

Research Interests

Keywords:

Topics:

Professional Links

SciProfiles

Selected Publications

Omega-3 reduces cardiovascular risk

Aggarwal R, Bhatt DL, Steg PG, Miller M, Brinton EA, et al. Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial. J Am Heart Assoc. 2025;14:e038656. doi:10.1161/JAHA.124.038656

PubMed DOI

Omega-3 benefits for smokers' heart health

Miller M, Bhatt DL, Steg PG, Brinton EA, Jacobson TA, et al. Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking. Eur Heart J Cardiovasc Pharmacother. 2023;9:129. doi:10.1093/ehjcvp/pvac045

PubMed DOI

Icosapent ethyl reduces cardiovascular events

Burger PM, Bhatt DL, Dorresteijn JAN, Koudstaal S, Mosterd A, et al. Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT. Eur Heart J Cardiovasc Pharmacother. 2024;10:488. doi:10.1093/ehjcvp/pvae030

PubMed DOI

Ph. Gabriel Steg

Education

Research Interests

Professional Links

Selected Publications

Related Products